Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2- bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines

Journal of Medicinal Chemistry

Volumn 42, Issue 5, 1999, Pages 941-946

  Shyam, Krishnamurthy ^a   Penketh, Philip G ^a   Shapiro, Maxim ^a   Belcourt, Michael F ^a   Loomis, Regina H ^a   Rockwell, Sara ^a   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; HYDRAZINE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CYTOTOXICITY; DIFFERENTIAL PULSE POLAROGRAPHY; DRUG MECHANISM; DRUG SYNTHESIS; HYPOXIC CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH MEASUREMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HYDRAZINES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 0033545676     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9805891     Document Type: Article

References (29)

1. Kennedy, K. A.; Teicher, B. A.; Rockwell, S.; Sartorelli, A. C. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem. Pharmacol. 1980, 29, 1-8.
2. Jenkins, T. C. Hypoxia-selective agenta: radiosensitizers and cytotoxins. In The Chemistry of Antitumor Agents; Wilman, D. E. V., Ed.; Blackie: Glasgow, 1990; pp 342-369.
3. Wilson, W. R.; Denny, W. A.; Twigden, S. J.; Baguely, B. C.; Probert, J. C. Selective toxicity of nitracrine to hypoxic mammalian cells. Br. J. Cancer 1984, 49, 215-223.
4. Zeman, E. M.; Brown, J. M.; Lemmon, M. J.; Hirst, V. K.; Lee, W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic cells. Int. J. Radiat. Oncol. Biol. Phys. 1986, 12, 1239-1242.
5. Teicher, B. A.; Sartorelli, A. C. Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agents. J. Med. Chem. 1980, 23, 955-960.
6. Kirkpatrick, D. L; Johnson, K. E.; Sartorelli, A. C. Nitrobenzyl derivatives as bioreductive alkylating agents: evidence for the reductive formation of a reactive intermediate. J. Med. Chem. 1986, 29, 2048-2052.
7. Tercel, M.; Wilson, W. R.; Denny, W. A. Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxin showing very high in vitro selectivity. J. Med. Chem. 1993, 36, 2578-2579.
8. Tercel, M.; Wilson, W. R.; Anderson, R. F.; Denny, W. A. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J. Med. Chem. 1996, 39, 1084-1094.
9. Mulcahy, R. T.; Gipp, J. J.; Schmidt, J. P.; Joswig, C.; Borch, R. F. Nitrobenzyl phosphorodiamidates as potential hypoxia-selective alkylating agents. J. Med. Chem. 1994, 37, 1610-1615.
10. Shyam, K.; Hrubiec, R. T.; Furubayashi, R.; Cosby, L. A.; Sartorelli, A. C. 1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity. J. Med. Chem. 1987, 30, 2157-2161.
11. Shyam, K.; Penketh, P. G.; Divo, A. A.; Loomis, R. H.; Patton, C. L.; Sartorelli, A. C. Synthesis and evaluation of 1,2,2-tris-(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. J. Med. Chem. 1990, 33, 2259-2264.
12. Shyam, K.; Penketh, P. G.; Divo, A. A.; Loomis, R. H.; Rose, W. C.; Sartorelli, A. C. Synthesis and evaluation of 1-acyl-1,2-bis-(methylsulfonyl)-2-(2-chloroethyl)hydrazines as antineoplastic agents. J. Med. Chem. 1993, 36, 3496-3502.
13. Shyam, K.; Penketh, P. G.; Loomis, R. H.; Rose, W. C.; Sartorelli, A. C. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines. J. Med. Chem. 1996, 39, 796-801.
14. Shyam, K.; Penketh, P. G.; Loomis, R. H.; Sartorelli, A. C. Thiolysable prodrugs of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-hydrazine with antineoplastic activity. Eur. J. Med. Chem. 1998, 33, 609-615.
15. Sykes, P. Guidebook to Mechanism in Organic Chemistry, 6th ed.; John Wiley: New York, 1986; pp 82-87.
16. Carpenter, F. H.; Gish, D. T. The application of p-nitrobenzyl chloroformate to peptide synthesis. J. Am. Chem. Soc. 1952, 74, 3818-3821.
17. Furniss, B. S.; Hannaford, A. J.; Rogers, V.; Smith, P. W. G.; Tatchell, A. R. Cognate preparation: m-nitrobenzyl alcohol. Vogel's Textbook of Practical Organic Chemistry, 4th ed.; Longman: London, 1978; p 357.
18. Rockwell, S.; Keyes, S. R.; Sartorelli, A. C. Preclinical studies of porfiromycin as an adjuvant to radiotherapy. Radiat. Res. 1988, 116, 100-113.
19. Keyes, S. R.; Rockwell, S.; Sartorelli, A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicumarol in vivo and in vitro. Cancer Res. 1986, 45, 213-216.
20. Rockwell, S.; Sartorelli, A. C. Mitomycin C and radiation. In Antitumor Drug-Radiation Interactions; Hill, B. T., Bellamy, A. S., Eds.; CRC Press: Boca Raton, FL, 1990; pp 125-139.
21. Rockwell, S. In vivo-in vitro tumor systems: new models for studying the response of tumors to therapy. Lab. Animal Sci. 1977, 27, 831-851.
22. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. The relevance of tumor pH to the treatment of malignant disease. Radiother. Oncol. 1984, 2, 343-366.
23. Vaupel, P. W.; Frinak, S.; Bicher, H. I. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res. 1981, 41, 2008-2013.
24. Gullino, P. M.; Grantham, F. H.; Smith, S. H.; Haggerty, A. C. Modifications of the acid-base status of the internal milieu of tumors. J. Natl. Cancer Inst. 1965, 34, 857-869.
25. Tannock, I. F.; Rotin, D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989, 49, 4373-4384.
26. 2 concentration in hepatocytes. J. Biol. Chem. 1978, 253, 4874-4880.
27. +]/[NADH] ratios in the cytoplasm and mitochondrial compartments of the liver cell. Regulation in Metabolism; John Wiley: London, 1977; pp 324-328.
28. Edwards, D. I. Reduction of nitroimidazoles in vitro and DNA damage. Biochem. Pharmacol. 1986, 35, 53-58.
29. Clarke, E. D.; Wardman, P.; Goulding, K. H. Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotides and by xanthine oxidase. Biochem. Pharmacol. 1980, 29, 2684-2687.